We found that loss of Tp53 function permitted markedly higher rates of hepatocyte growth and liver enlargement in the larval, mutant kras-driven model of HCC, whether they were WT or heterozygous for ahctf1. The gene discussed is TP53; the disease is hepatocellular carcinoma.